Clinical trial design for phase 1 studies of drug combinations
Clin Adv Hematol Oncol
.
2014 May;12(5):335-7.
Author
Channing Paller
1
Affiliation
1
National Cancer Institute, Bethesda, Maryland.
PMID:
25003492
PMCID:
PMC8517730
No abstract available
MeSH terms
Antineoplastic Agents / administration & dosage*
Clinical Trials, Phase I as Topic / methods*
Drug Therapy, Combination / methods*
Humans
Neoplasms / drug therapy*
Research Design*
Substances
Antineoplastic Agents
Grants and funding
P30 CA006973/CA/NCI NIH HHS/United States